Scancell Holdings plc Share Price
Stocks
SCLP
GB00B63D3314
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.80 GBX | +0.34% |
|
-15.43% | +49.49% |
| 06-28 | Scancell Is in Talks over Possible Equity and Debt Financing | CI |
| 06-26 | Neuphoria Confirms Business Combination Talks With Scancell | MT |
| Market Cap | 153M 204M 179M 165M 291M 19.5B 295M 1.97B 768M 9.57B 768M 751M 33.19B | P/E 2026 * |
-9.86x | P/E 2027 * | -18.7x |
|---|---|---|---|---|---|
| Enterprise Value | 163M 218M 191M 176M 310M 20.83B 315M 2.11B 821M 10.22B 820M 802M 35.45B | EV / Sales 2026 * |
131x | EV / Sales 2027 * | 70.4x |
| Free-Float |
96.34% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Scancell Holdings plc
| 1 day | +0.34% | ||
| 1 week | -15.43% | ||
| Current month | -15.43% | ||
| 1 month | -31.95% | ||
| 3 months | +28.70% | ||
| 6 months | +48.00% | ||
| Current year | +49.49% |
| 1 week | 14 |  | 18 |
| 1 month | 14 | | 23 |
| Current year | 9.5 | | 29.5 |
| 1 year | 7.86 | | 29.5 |
| 3 years | 7.26 | | 29.5 |
| 5 years | 7.26 | | 29.5 |
| 10 years | 0.11 | | 29.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Durrant
CEO | Chief Executive Officer | 69 | 27/07/2021 |
| Chief Executive Officer | 64 | 17/11/2024 | |
David Schilansky
DFI | Director of Finance/CFO | 50 | 23/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Linda Durrant
BRD | Director/Board Member | 69 | 16/11/2010 |
Ursula Ney
BRD | Director/Board Member | 74 | 22/10/2019 |
Susan Davies
BRD | Director/Board Member | 64 | 23/09/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/09/25 | Vulpes Investment Management Pte Ltd.
| Buy | Company | 3,150,000 | 0.3038% | |
| 07/08/25 | Vulpes Investment Management Pte Ltd.
| Buy | Company | 102,236 | 0.0099% | |
| 03/08/25 | Vulpes Investment Management Pte Ltd.
| Buy | Company | 4,400,000 | 0.4244% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.34% | -15.43% | +51.79% | +12.76% | 204M | |
| +0.09% | +6.23% | +3.91% | +10.44% | 50.25B | |
| +0.40% | -1.37% | +401.69% | +625.15% | 40.39B | |
| -0.52% | +6.57% | +25.41% | -5.37% | 34.38B | |
| +3.97% | +6.71% | +26.06% | +63.36% | 34.4B | |
| -4.19% | -1.84% | +3.76% | +32.17% | 26.32B | |
| -2.40% | +1.60% | - | - | 16.64B | |
| +1.34% | +5.68% | +75.77% | +141.51% | 16.14B | |
| +2.07% | +2.25% | +16.29% | +23.55% | 13.71B | |
| +1.69% | +3.09% | +93.44% | +99.19% | 13.75B | |
| Average | +0.28% | +2.02% | +77.57% | +111.42% | 24.62B | |
| Weighted average by Cap. | +0.25% | +4.02% | +91.62% | +141.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.25M 1.67M 1.46M 1.35M 2.37M 159M 2.41M 16.12M 6.27M 78.17M 6.27M 6.13M 271M | 2.4M 3.21M 2.81M 2.59M 4.56M 306M 4.62M 30.95M 12.05M 150M 12.04M 11.77M 520M |
| Net income | -19.23M -25.69M -22.5M -20.72M -36.52M -2.45B -37.02M -248M -96.53M -1.2B -96.47M -94.35M -4.17B | -8.24M -11M -9.63M -8.87M -15.64M -1.05B -15.85M -106M -41.34M -515M -41.31M -40.41M -1.79B |
| Net Debt | 10.42M 13.91M 12.18M 11.22M 19.78M 1.33B 20.05M 134M 52.28M 651M 52.24M 51.1M 2.26B | 15.87M 21.2M 18.57M 17.1M 30.14M 2.02B 30.55M 205M 79.67M 993M 79.62M 77.87M 3.44B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | GBX 14.80 | +0.34% | 164,429 |
| 06/07/26 | GBX 14.75 | +3.51% | 2,226,300 |
| 03/07/26 | GBX 14.25 | -5.00% | 2,562,904 |
| 02/07/26 | GBX 15.00 | -10.71% | 3,294,950 |
| 01/07/26 | GBX 16.80 | -4.00% | 1,615,746 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCLP Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
